GSRX Industries Inc. (GSRX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | -100.0% |
| 2019 | 2.34 Million USD | 213188.45% |
| 2018 | 1100.00 USD | 10.0% |
| 2017 | 1000.00 USD | -99.8% |
| 2016 | 496.61 Thousand USD | 14.33% |
| 2015 | 434.36 Thousand USD | 14.94% |
| 2014 | 377.9 Thousand USD | 18.61% |
| 2013 | 318.61 Thousand USD | 21.63% |
| 2012 | 261.95 Thousand USD | 30.49% |
| 2011 | 200.74 Thousand USD | 36.76% |
| 2010 | 146.78 Thousand USD | 62.28% |
| 2009 | 90.45 Thousand USD | 162.05% |
| 2008 | 34.51 Thousand USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 1000.00 USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 FY | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2020 Q2 | 1.52 Million USD | -31.3% |
| 2020 FY | - USD | -100.0% |
| 2020 Q3 | 1.43 Million USD | -6.12% |
| 2020 Q1 | 2.22 Million USD | -5.25% |
| 2019 FY | 2.34 Million USD | 213188.45% |
| 2019 Q2 | 2.84 Million USD | -55.68% |
| 2019 Q1 | 6.42 Million USD | 584166.27% |
| 2019 Q3 | 2.71 Million USD | -4.6% |
| 2019 Q4 | 2.34 Million USD | -13.65% |
| 2018 Q4 | 1100.00 USD | 0.0% |
| 2018 FY | 1100.00 USD | 10.0% |
| 2018 Q2 | 2522.00 USD | 152.2% |
| 2018 Q3 | 1100.00 USD | -56.38% |
| 2018 Q1 | 1000.00 USD | 0.0% |
| 2017 Q2 | 1000.00 USD | -99.8% |
| 2017 Q4 | 1000.00 USD | 0.0% |
| 2017 FY | 1000.00 USD | -99.8% |
| 2017 Q1 | 510.65 Thousand USD | 2.83% |
| 2017 Q3 | 1000.00 USD | 0.0% |
| 2016 Q4 | 496.61 Thousand USD | 3.32% |
| 2016 Q2 | 463.67 Thousand USD | 2.43% |
| 2016 FY | 496.61 Thousand USD | 14.33% |
| 2016 Q1 | 452.67 Thousand USD | 4.21% |
| 2016 Q3 | 480.63 Thousand USD | 3.66% |
| 2015 Q4 | 434.36 Thousand USD | 4.27% |
| 2015 FY | 434.36 Thousand USD | 14.94% |
| 2015 Q3 | 416.58 Thousand USD | 3.29% |
| 2015 Q2 | 403.31 Thousand USD | 2.81% |
| 2015 Q1 | 392.29 Thousand USD | 3.81% |
| 2014 Q2 | 345.41 Thousand USD | 3.29% |
| 2014 Q1 | 334.41 Thousand USD | 4.96% |
| 2014 FY | 377.9 Thousand USD | 18.61% |
| 2014 Q4 | 377.9 Thousand USD | 3.92% |
| 2014 Q3 | 363.65 Thousand USD | 5.28% |
| 2013 Q1 | 273.9 Thousand USD | 4.56% |
| 2013 Q2 | 291.03 Thousand USD | 6.25% |
| 2013 Q4 | 318.61 Thousand USD | 4.54% |
| 2013 FY | 318.61 Thousand USD | 21.63% |
| 2013 Q3 | 304.78 Thousand USD | 4.73% |
| 2012 Q2 | - USD | -100.0% |
| 2012 FY | 261.95 Thousand USD | 30.49% |
| 2012 Q4 | 261.95 Thousand USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q1 | 213.94 Thousand USD | 6.58% |
| 2011 Q1 | 165.33 Thousand USD | 12.64% |
| 2011 Q4 | 200.74 Thousand USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | -100.0% |
| 2011 FY | 200.74 Thousand USD | 36.76% |
| 2010 Q1 | 109.08 Thousand USD | 20.61% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | 146.78 Thousand USD | 62.28% |
| 2010 Q4 | 146.78 Thousand USD | 0.0% |
| 2010 Q2 | - USD | -100.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 FY | 90.45 Thousand USD | 162.05% |
| 2009 Q4 | 90.45 Thousand USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q1 | - USD | -100.0% |
| 2008 FY | 34.51 Thousand USD | 0.0% |
| 2008 Q3 | 19.61 Thousand USD | 141.78% |
| 2008 Q4 | 34.51 Thousand USD | 76.01% |
| 2008 Q2 | 8111.00 USD | 62292.31% |
| 2008 Q1 | 13.00 USD | 0.0% |
| 2007 FY | - USD | -100.0% |
| 2007 Q3 | - USD | -100.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q1 | 6000.00 USD | 0.0% |
| 2007 Q2 | 7540.00 USD | 25.67% |
| 2006 FY | 1000.00 USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| BioQuest Corp. | 183.3 Thousand USD | 100.0% |
| High Sierra Technologies, Inc. | 482.04 Thousand USD | 100.0% |
| Instadose Pharma Corp. | - USD | NaN% |